---
title: "Olymvax Biopharmaceuticals terminates the issuance of stocks to specific objects"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255331435.md"
description: "Olymvax Biopharmaceuticals announced the termination of the issuance of shares to specific objects, citing market conditions and the company's development plan as reasons. The company stated that production and operations are normal, the technical transformation project of the vaccine research and production base is progressing as planned, and the termination of the issuance will not have a significant impact on daily operations, nor will it harm the interests of the company and its shareholders"
datetime: "2025-08-31T07:52:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255331435.md)
  - [en](https://longbridge.com/en/news/255331435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255331435.md)
---

# Olymvax Biopharmaceuticals terminates the issuance of stocks to specific objects

According to the announcement from Zhitong Finance APP, Olymvax Biopharmaceuticals (688319.SH) has stated that since the company first announced the issuance of stocks to specific targets through a simplified procedure, the company's board of directors, management, and intermediary institutions have been actively promoting various tasks. In light of the current market situation, combined with the company's actual circumstances and development plans, after careful analysis, the company has decided to terminate the relevant matters regarding the issuance of stocks to specific targets through a simplified procedure.

As of now, the company's production and operations are all normal, and the "Vaccine Research and Production Base Technical Transformation Project" is still progressing in an orderly manner as planned. The termination of this stock issuance to specific targets will not have a significant adverse impact on the company's daily production and operations, and there is no situation that harms the interests of the company and all shareholders

### Related Stocks

- [688319.CN](https://longbridge.com/en/quote/688319.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [08:59 ETPurina Institute Drives the Conversation on Microbiome Innovation in Veterinary Medicine](https://longbridge.com/en/news/286917434.md)
- [15:43 ETUnleashed Brands Foundation Donates $200,000 to Blood Cancer United in Support of Pediatric Blood Cancer Patients & Their Families](https://longbridge.com/en/news/286811594.md)
- [Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer](https://longbridge.com/en/news/286856224.md)